A major cardiology trial called ZEUS tested a monthly injection that successfully reduced inflammation markers in high-risk heart patients. The drug worked exactly as designed. Cardiovascular deaths, heart attacks, and strokes were completely unchanged. The inflammatory hypothesis just got much harder to defend.
.png)
